Literature DB >> 12117385

Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.

J Eric Ahlskog, Demetrius M Maraganore, Ryan J Uitti, George R Uhl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12117385

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys.

Authors:  Yunlong Tao; Scott C Vermilyea; Matthew Zammit; Jianfeng Lu; Miles Olsen; Jeanette M Metzger; Lin Yao; Yuejun Chen; Sean Phillips; James E Holden; Viktoriya Bondarenko; Walter F Block; Todd E Barnhart; Nancy Schultz-Darken; Kevin Brunner; Heather Simmons; Bradley T Christian; Marina E Emborg; Su-Chun Zhang
Journal:  Nat Med       Date:  2021-03-01       Impact factor: 53.440

2.  N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data.

Authors:  Daniel A Monti; George Zabrecky; Daniel Kremens; Tsao-Wei Liang; Nancy A Wintering; Jingli Cai; Xiatao Wei; Anthony J Bazzan; Li Zhong; Brendan Bowen; Charles M Intenzo; Lorraine Iacovitti; Andrew B Newberg
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

3.  Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.

Authors:  Jeffrey N Joyce; Cheryl Woolsey; Han Ryoo; Sabine Borwege; Diane Hagner
Journal:  BMC Biol       Date:  2004-10-11       Impact factor: 7.431
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.